Cotranslational N-glycosylation can accelerate protein folding, slow protein unfolding, and increase protein stability, but the molecular basis for these energetic effects is incompletely understood. N-glycosylation of proteins at naïve sites could be a useful strategy for stabilizing proteins in therapeutic and research applications, but without engineering guidelines, often results in unpredictable changes to protein energetics. We recently introduced the enhanced aromatic sequon as a family of portable structural motifs that are stabilized upon glycosylation in specific reverse turn contexts: a five-residue type I β-turn harboring a G1 β-bulge (using a Phe-Yyy-Asn-Xxx-Thr sequon) and a type II β-turn within a sixresidue loop (using a Phe-Yyy-Zzz-Asn-Xxx-Thr sequon) [Culyba EK, et al. (2011) Science 331:571-575]. Here we show that glycosylating a new enhanced aromatic sequon, Phe-Asn-Xxx-Thr, in a type I′ β-turn stabilizes the Pin 1 WW domain. Comparing the energetic effects of glycosylating these three enhanced aromatic sequons in the same host WW domain revealed that the glycosylation-mediated stabilization is greatest for the enhanced aromatic sequon complementary to the type I β-turn with a G1 β-bulge. However, the portion of the stabilization from the tripartite interaction between Phe, Asn(GlcNAc), and Thr is similar for each enhanced aromatic sequon in its respective reverse turn context. Adding the Phe-Asn-Xxx-Thr motif (in a type I′ β-turn) to the enhanced aromatic sequon family doubles the number of proteins that can be stabilized by glycosylation without having to alter the native reverse turn type.
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glycoprotein | biopharmaceutical | conjugate | native state stabilization | β-sheet N early 1∕3 of the eukaryotic proteome traverses the cellular secretory pathway (1) . Many of these proteins are cotranslationally N-glycosylated at Asn residues within the conserved Asn-Xxx-Thr/Ser sequon. The oligosaccharyl transferase enzyme complex transfers the Glc 3 Man 9 GlcNAc 2 (where Glc is glucose, Man is mannose, and GlcNAc is N-acetylglucosamine) oligosaccharide as one structural unit onto the nascent polypeptide as it is translocated into the endoplasmic reticulum (2) (3) (4) . The N-linked oligosaccharide, or N-glycan, promotes glycoprotein folding in the endoplasmic reticulum by allowing the glycoprotein to enter the calnexin/calreticulin-assisted folding vs. degradation cycle (5, 6) . Glycans can also intrinsically accelerate protein folding (7, 8) , promote secondary structure formation (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) , and increase protein thermodynamic stability (8, 25, 26) , but the molecular basis for these effects is incompletely understood (27) .
We recently demonstrated that glycosylation of an Asn residue within the sequence Phe-Yyy-Asn-Xxx-Thr (where Yyy can likely be any amino acid and Xxx is any amino acid but Pro) stabilizes the glycosylation-naïve rat CD2 adhesion domain (RnCD2ad) and human muscle acylphosphatase (AcyP2) by approximately −2 kcal mol −1 , provided that Asn is located at the i þ 2 position of a type I β-turn with a G1 β-bulge (28, 29), hereafter called a type I β-bulge turn (30) . Published structural data (31) from the human ortholog of RnCD2ad (HsCD2ad, Fig. 1A ) suggest that placement of an N-glycan at i þ 2 in the type I β-bulge turn context allows the α-face of GlcNAc1 of the N-glycan to engage in stabilizing hydrophobic interactions with the aromatic ring of Phe at the i position (a stabilizing C-H∕π interaction may also play a role), and the sidechain methyl group of Thr at the i þ 4 position (32). We call the Phe-Yyy-Asn-Xxx-Thr sequence an "enhanced aromatic sequon" because of its increased propensity to form a stabilizing compact structure upon glycosylation, relative to the canonical Asn-XxxThr sequon, and because it is more efficiently glycosylated by the cell than the Asn-Xxx-Thr sequon (30) .
Nearly 9% of the reverse turns in the Protein Data Bank (PDB) are type I β-bulge turns (28, 33) , so installing the Phe-YyyAsn-Xxx-Thr enhanced aromatic sequon could be an attractive strategy for increasing the stability of the many proteins that harbor type I β-bulge turns. Identifying other suitable reverse turn types that could position Phe, GlcNAc1, and Thr close enough to facilitate a tripartite interaction would further expand the number of proteins that could benefit from the increased stability and possibly the increased glycosylation efficiency afforded by the enhanced aromatic sequon.
Our previous efforts to apply the enhanced aromatic sequon to other types of reverse turns employed the WW domain of the human protein Pin1 (WW) (30), a glycosylation-naïve protein in which three antiparallel β-strands are connected by two reverse turns (34) . In wild-type WW, loop 1 adopts an unusual six-residue hydrogen-bonded loop harboring an internal type II β-turn (Fig. 1B) ; 0.1% of the reverse turns in the PDB have this conformation (33) . The side-chain beta carbons (Cβ's) at the i, i þ 3, and i þ 5 positions of this loop are within 4.0-4.6 Å of each other; close enough to facilitate a stabilizing interaction between Phe, GlcNAc1 and Thr, similar to the interactions observed in the glycosylated type I β-bulge turn of HsCD2ad (Fig. 1A) . Grafting these residues onto the i, i þ 3, and i þ 5 positions of the sixresidue loop generated a modified enhanced aromatic sequon with the sequence Phe-Yyy-Zzz-Asn-Xxx-Thr (where Yyy and Zzz can likely be any amino acid).
Chemical glycosylation of the Phe-Yyy-Zzz-Asn-Xxx-Thr sequon (with a single GlcNAc, GlcNAc1) in the six-residue loop of WW increased the stability of the resulting WW variant by −0.7 kcal mol −1 (30), a smaller effect than observed for the Phe-Yyy-Asn-Xxx-Thr sequon in the type I β-bulge turns of RnCD2 and AcyP2 (ΔΔG f ¼ −1.8 kcal mol −1 , −2.5 kcal mol −1 , respectively). One possible interpretation of these results is that the type II β-turn within the six-residue loop does not promote the stabilizing tripartite interaction between Phe, GlcNAc, and Thr as effectively as does the five-residue type I β-bulge turn. However, key host context differences between WW, RnCD2, and AcyP2 could also be partially responsible for these observations, including differences in folding topology and mechanism (35) , and differences in the amino acids that flank the glycosylated reverse turns (30) . Moreover, because the WW domain is synthesized chemically via a solid-phase strategy, the N-glycan in WW (GlcNAc) is much smaller than the N-glycans in RnCD2 (oligomannose) and AcyP2 (fucosylated paucimannose). Interactions between the host sequences and these extended glycans could also contribute to the stabilization associated with glycosylating the Phe-Yyy-Asn-Xxx-Thr sequon in the type I β-bulge turns within RnCD2 and AcyP2.
The studies reported herein have two aims: To add to the number of reverse turn types into which stabilizing enhanced aromatic sequons can be placed and to enable direct stability comparisons of glycosylated enhanced aromatic sequons in different reverse turn types within the same host protein. To meet these goals, we sought a single protein into which several types of enhanced aromatic sequons and their corresponding reverse turn types could be inserted without changing the overall structure or the flanking sequences. The WW domain is ideal for these requirements: Many WW variants harboring different reverse turn types in loop 1 have been structurally (34, 36, 37) and biophysically (36) (37) (38) (39) characterized. Crystal structures exist for WW domains harboring a type II β-turn in a six-residue loop (Fig. 1B) , a five-residue type I β-bulge turn (Fig. 1C) , and a four-residue type I′ β-turn (Fig. 1D ) as loop 1 (34, 36) . We hypothesized that a type I′ β-turn, which makes up 11% of the reverse turns in the PDB (33) , would also be an additional conformational host for a complementary enhanced aromatic sequon: the Cβ's of the side chains at the i, i þ 1, and i þ 3-positions are close enough (<5.6 Å; see Fig 1D) to support a stabilizing tripartite interaction among Phe, Asn (GlcNAc1), and Thr. Importantly, the chemical synthesis of homogeneously glycosylated (40) WW domains is efficient (30, 41) enabling numerous analogs to be prepared, each having an identical N-glycan (in this case, GlcNAc1). Our data show that type I′ β-turns are suitable conformational hosts for a stabilizing enhanced aromatic sequon. This result significantly expands the scope of protein stabilization by glycosylating enhanced aromatic sequons. Furthermore, our data show that the order of stabilization by glycosylating enhanced aromatic sequons in the different turn types is: type I β-bulge turns > type II β-bulge turns in a sixresidue loop > type I′ β-turns.
Results
Strategy and Nomenclature. The four-, five-, and six-residue reverse turns comprising loop 1 of WW were converted to their corresponding enhanced aromatic sequons by replacing the amino acid at position 16 (Ser in all cases) with Phe, replacing the amino acid at position 19 (Asn, Asp, or Ser, respectively) with Asn (GlcNAc1), and replacing the amino acid at position 21 (Arg in all cases) with Thr (36, 38) . Note that we are using the same number to indicate amino acids in analogous positions in WW variants with different loop 1 lengths (36, 37) . Thus, the sequences of the enhanced aromatic sequons in the four-, five-, and six-residue reverse turns comprising loop 1 are Phe16-Asn(GlcNAc1)19-Gly20-Thr21, Phe16-Ala18-Asn(GlcNAc1)19-Gly20-Thr21, and Phe16-Arg17-Ser18--Asn(GlcNAc1)19-Gly20-Thr21, respectively (see Table 1 ).
The stabilizing effect of glycosylating enhanced aromatic sequons can be quantified by comparing the stabilities of WW variants with glycosylated enhanced aromatic sequons to the stabilities of their nonglycosylated counterparts. The contributions of two-and three-way interactions amongst the Phe16, Asn(GlcNAc1)19, and Thr21 side chains to the overall stabilizing effect of glycosylation can be estimated using triple mutant cycle analyses, as we have done previously (30) . This parsing of stabilization energies through energetic comparisons was accomplished by replacing Phe16, Asn(GlcNAc1)19, and Thr21 with Ser16, Asn19, and Arg21, respectively, in every possible combination, for a total of eight proteins in each of the three correlated enhanced aromatic sequon-reverse turn contexts. The results of these analyses are described in the sections below.
The WW variants are named by the number of amino acids in the loop 1 reverse turn, followed by the letter "g" if the variant is N-glycosylated on Asn19, the letter "F" if it has Phe at position 16, and the letter "T" if it has Thr at position 21. The lack of the letters g, F, and/or T indicates that the variant is not N-glycosylated on Asn19, that position 16 is Ser, and/or that position 21 is Arg, respectively. Table 1 for the names of the WW variants studied).
Stabilization from Glycosylating Enhanced Aromatic Sequons. To quantify the stabilizing effect of glycosylating enhanced aromatic sequons in loop 1 of the corresponding four-, five-, and six-residue reverse turns, we used variable temperature circular dichroism (CD) spectropolarimetry to analyze the thermodynamic stability of WW variants 4-F,T, 4g-F,T, 5-F,T, 5g-F,T, 6-F,T, and 6g-F,T. CD data for 6-F,T and 6g-F,T and their derivatives (described below) have been published previously at a protein concentration of 50 μM (30), but were restudied herein at a protein concentration of 10 μM (the energetic data are comparable at both concentrations) to facilitate direct comparisons with 4-F,T, 4g-F,T, 5-F,T, and 5g-F,Tand their derivatives (some of which were not completely soluble at 50 μM). Table 1 shows the melting temperature T m and free energy of folding ΔG f (at 65°C) for each protein and corresponding glycoprotein, along with the effect of glycosylation on the T m and ΔG f (at 65°C) for each protein (complete CD spectra and variable temperature CD data for 4, 5, and 6 and their derivatives are shown in Figs. S1-S3, respectively). We use 65°C as a reference temperature because it is within the transition regions of all the variants studied herein. Extrapolating ΔG f to temperatures outside the transition region using thermodynamic parameter estimates from fits to variable temperature CD data is unreliable (because errors in ΔC p , the least-well defined parameter from such fits, become magnified outside the transition region; see SI Text and Figs. S1-S3). For sets of proteins with similar ΔC p values, the differences between their T m values should reflect the differences between their ΔG f values both at 65°C and at lower temperatures.
The T m of glycoprotein 4g-F,T is 3.2 AE 0.7°C higher than that of protein 4-F,T (ΔΔG f ¼ −0.39 AE 0.09 kcal mol −1 at 65°C), indicating that glycosylating the Phe-Asn-Xxx-Thr enhanced aromatic sequon in the context of a four-residue type I′ β-turn stabilizes WW. Glycosylating the Phe-Yyy-Asn-Xxx-Thr sequon in the context of the five-residue type I β-turn also stabilizes WW (ΔT m ¼ 9.2 AE 0.2°C, ΔΔG f ¼ −0.94 AE 0.03 kcal mol −1 at 65°C), as does glycosylating the Phe-Yyy-Zzz-Asn-Xxx-Thr sequon in the type II β-turn in a six-residue loop (ΔT m ¼ 7.6 AE 0.5°C, ΔΔG f ¼ −0.70 AE 0.10 kcal mol −1 at 65°C). These data indicate that the Phe-Yyy-Asn-Xxx-Thr enhanced aromatic sequon corresponding to the five-residue type I β-bulge turn is, overall, the best for stabilizing WW amongst those studied here.
Interaction Energies in Enhanced Aromatic Sequons from Triple
Mutant Cycle Analysis. To determine whether the Phe, Asn (GlcNAc1) and Thr side chains interact similarly in each correlated enhanced aromatic sequon/reverse turn context, we measured the thermodynamic stabilities of each WW variant in the four-, five-, and six-residue reverse turn groups in Table 1 . The data from each group of eight WW variants make a triple mutant cycle (Fig. 2) . Triple mutant cycles contain more information than conventional double mutant cycles, because each of the six "faces" of a triple mutant cycle "cube" is itself a double mutant cycle (42) . Whereas double mutant cycles provide information about the energetic impact of an interaction between two residues, a triple mutant cycle provides information about the energetic impact of the two-and three-way interactions.
Extracting this information from a triple mutant cycle is straightforward, and begins with analyzing the double mutant cycle faces of the triple mutant cycle cube (Fig. 2) . The double mutant cycle formed by proteins 4 and 4-F and glycoproteins 4g and 4g-F (the front face of the triple mutant cycle cube in Fig. 2A) , reveals that glycosylation of Asn19 (in the presence of Arg21) stabilizes glycoprotein 4g relative to protein 4 (ΔΔG f ;1 ¼ −0.23AE 0.06 kcal mol −1 at 65°C). Similarly, glycosylation of Asn19 (in the presence of Arg 21) stabilizes 4g-F relative to 4g (ΔΔG f ;2 ¼ −0.18 AE 0.08 kcal mol −1 at 65°C). The difference between ΔΔG f ;2 and ΔΔG f ;1 (ΔΔΔG f ;front ¼ 0.05 AE 0.10 kcal mol −1 at 65°C) indicates that changing Ser16 to Phe16 (while keeping Arg21 constant) does not significantly change the effect of glycosylating Asn19 in the four-residue type I′ β-turn. In other words, Phe16 and Asn(GlcNAc1)19 do not interact favorably in 4g-F. Changing Arg21 to Thr21 changes this trend. The double mutant cycle formed by proteins 4-T, 4g-T, 4-F,T, and 4g-F,T (the back face of the triple mutant cycle cube shown in Fig. 2A ) reveals that in the presence of Thr21 (instead of Arg21), Phe16 and Asn(GlcNAc1) interact favorably (ΔΔΔG f ;back ¼ −0.46 AE 0.11 kcal mol −1 at 65°C). The difference between the front and back double mutant cycles is an estimate of the energy of the three-way interaction between Phe16, Asn(GlcNAc1)19, and Thr21. The large difference between ΔΔΔG f ;back and ΔΔΔG f ;front for the four-residue type I′ β-turn (ΔΔΔΔG f ¼ −0.51 AE 0.15 kcal mol −1 at 65°C) indicates that Phe16, Asn(GlcNAc1) 19 and Thr21 engage in a favorable three-way interaction in 4g-F,T.
Similar analyses of the triple mutant cycles formed by proteins 5 and 6 and their derivatives (Fig. 2 B and C) reveal a favorable interaction between Phe16, Asn(GlcNAc1)19, and Thr21 in the five-residue type I β-bulge turn (ΔΔΔΔG f ¼ −0.23 AE 0.07 kcal mol −1 at 65°C) and in the type II β-turn in a six-residue loop (ΔΔΔΔG f ¼ −0.36 AE 0.15 kcal mol −1 at 65°C). This threeway interaction between Phe16, Asn(GlcNAc1)19, and Thr21 is similarly favorable in each reverse turn context (perhaps more favorable in the type I′ β-turn than in the type I β-bulge turn, but recall that this is only part of the overall stabilizing effect of N-glycosylation).
The attribution of ΔΔΔG f ;front and ΔΔΔG f ;back values to the interaction between Phe16 and Asn(GlcNAc1)19, and of ΔΔΔΔG f to the tripartite interaction among Phe16, Asn(GlcNAc1)19, and Thr21, assumes that the Ser16 side chain does not interact with the side chains at positions 19 or 21, and that the Arg21 side chain does not interact with the side chains at positions 16 or 19, in any variant. This assumption is, to a first approximation, consistent with the available structural data. Crystal structures of WW in the context of the full-length Pin1 protein (34, 36) show that the side chains at positions 16, 19, and 21 generally interact only with solvent or the main chain (see Fig. 1 B-D) . The lone exception is an interaction between the side-chain hydroxyl of Ser16 and the side-chain carboxylate of Asp19 in the type I β-bulge turn (Fig. 1C) . However, the equivalent interaction (between the Ser16 hydroxyl and the Asn19 side-chain carbonyl) in the variants of 5 that have Ser at position 16 (5, 5g, 5-T, and 5g-T) should be the same whether Asn19 is N-glycosylated or not, and thus should not affect our analysis. We also note that the reverse turn structures are likely to depend primarily on loop length and the identities of a few key residues (e.g., Asn19 and Gly20 in the variants of 4 and Gly20 in the variants of 5, because these amino acids are strongly favored in these positions of type I′ β-turns and type I β-bulge turns, respectively) (28, 36) . Because these factors are kept constant within the variants that make up each triple mutant cycle, the corresponding reverse turn structures should remain roughly constant as well.
Estimates for Interaction Energies from Linear Regression on Triple
Mutant Cycle Data. We used least-squares regression to extract additional information about interactions amongst Phe, Asn (GlcNAc1), and Thr from the triple mutant cycles formed by WW variant groups 4, 5, and 6. We fit the folding free energy data (at 65°C) from the triple mutant cycle formed by 4 and its derivatives to the following equation:
Eq. 1 shows how the ΔG f of a given variant of 4 is related to the average ΔG f o of 4, plus a series of correction terms that account for the interactions amongst the amino acids at positions 16, 19, and 21 . Each correction term is a product of one or more indicator variables W (which reflect whether a mutation is present in the given variant) and a free energy contribution factor C. W F is 0 when position 16 is Ser or 1 when it is Phe; W N is 0 when position 19 is Asn or 1 when it is Asn(GlcNAc1); W T is 0 when position 21 is Arg or 1 when it is Thr. C F , C N , and C T describe the energetic consequences of the Ser16 to Phe16, Asn19 to Asn (GlcNAc1)19, and Arg21 to Thr21 mutations, respectively. These energies probably primarily reflect the difference in conformational preferences between Ser and Phe at position 16, Asn and Asn(GlcNAc1) at position 19, and Arg and Thr at position 21. C F;N , C F;T , and C N;T describe the free energies of the two-way interactions between Phe16 and Asn(GlcNAc1)19, between Phe16 and Thr21, and between Asn(GlcNAc1)19 and Thr21, respectively. C F;N;T describes the energetic impact of the three-way interaction between Phe16, Asn(GlcNAc1)19, and Thr21. C F;N , C F;T , C N;T , and C F;N;T are essentially equivalent to the two-and three-way interaction energies (ΔΔΔG f and ΔΔΔΔG f values) that could be calculated by a conventional analysis (e.g., as in the preceding section) of the triple mutant cycle data (42), but obtaining them by regression is more convenient, and automatically gives their standard errors in the regression output. Similar analyses were performed for 5 and 6 and their derivatives, and the results are shown in Table 2 . Note that the caveats to the conventional analysis of triple mutant cycle data mentioned in the preceding section apply to this analysis as well.
According to Eq. 1, the stabilizing effect of glycosylating the enhanced aromatic sequon in 4-F,T [ΔΔG f ¼ ΔG f ð4g-F;TÞ-ΔG f ð4-F;TÞ] is equal to the sum of the corresponding values of C N , C F;N , C N;T , and C F;N;T . The same is true for 5-F,T and 6-F,T. Thus, by comparing C N , C F;N , C N;T , and C F;N;T values we can trace the origins of the stabilizing effect of glycosylating the enhanced aromatic sequon in each reverse turn context (Fig. 3) .
Changing Asn19 to Asn(GlcNAc1)19 affects each turn type differently: it stabilizes the four-residue type I′ β-turn (C N ¼ −0.23 AE 0.08 kcal mol −1 ), does not affect the five-residue type I β-bulge turn substantially (C N ¼ −0.07 AE 0.06 kcal mol −1 ), and destabilizes the type II β-turn within a six-residue loop (C N ¼ 0.21 AE 0.06 kcal mol −1 ). It is possible that Asn(GlcNAc1) has backbone dihedral angle preferences that are more compatible with the i þ 1 position of a type I′ β-turn than with the i þ 2 position of a type I β-bulge turn or with the i þ 3 position of a type II β-turn. If so, such preferences would differ substantially from those of Asn itself (43), which is favored at i þ 1 in a type I′ β-turn, and at i þ 2 in a type I β-turn, but not at i þ 3 in a type II β-turn (44).
The two-way interaction between Phe16 and Asn(GlcNAc1)19 stabilizes the five-residue type I β-bulge turn (C F;N ¼ −0.48 AE 0.09 kcal mol −1 ) and the type II β-turn within a the six-residue loop (C F;N ¼ −0.38 AE 0.08 kcal mol −1 ), but does not substantially change the stability of the four-residue type I′ β-turn (C F;N ¼ 0.05 AE 0.11 kcal mol −1 ). These differences appear not to correlate with differences among the Cβ-Cβ distances between positions 16 and 19 in the four-, five-, and six-residue turns (Fig. 1 B-D) , Table 2 . Triple mutant cycle analysis of folding free energy data at 65°C (338.15 K) for glycosylated and nonglycosylated WW variants harboring either a four-, five-, or six-residue reverse turn in loop 1* (31) indicate that the glycosylated enhanced aromatic sequon in an analogous type I β-bulge turn in HsCD2ad involves three hydrogen bonds between Thr and Asn(GlcNAc1): one between the Thr side-chain oxygen and the amide proton of the 2-acetamido group of GlcNAc, and two between the Asn side-chain amide carbonyl oxygen and the backbone amide and side-chain hydroxyl protons of Thr (Fig. 1A) . The differences we observe between the C N;T values in the four-, five-, and six-residue turn contexts could reflect the presence of analogous hydrogen bonds in the type I β-bulge turn of 5g-F,Tand in six-residue loop of 6g-F,T, but not in the type I′ β-turn of 4g-F,T.
The 
Discussion
Glycosylating an enhanced aromatic sequon in its correlated reverse turn context is stabilizing, though the origins of this stabilizing effect differ amongst the enhanced aromatic sequon/ reverse turn pairs (Fig. 3) . In the type I′ β-turn, this effect comes predominantly from the three-way interaction between Phe16, Asn(GlcNAc1)19, and Thr21 (C F;N;T ) and from the Asn19 to Asn(GlcNAc1)19 mutation (C N ), offset by an unfavorable twoway interaction between Asn(GlcNAc1)19 and Thr21 (C N;T ). In the type I β-bulge turn, the two-way interaction between Phe16 and Asn(GlcNAc1)19 (C F;N ) contributes more than does the three-way interaction between Phe16, Asn(GlcNAc1)19, and Thr21 (C F;N;T ). In the type II β-turn within a six-residue loop, the two-way interaction between Phe16 and Asn(GlcNAc1)19 (C F;N ) and the three-way interaction between Phe16, Asn(GlcNAc1) 19 and Thr21 (C F;N;T ) contribute similar amounts, offset by the unfavorable effect of the Asn19 to Asn(GlcNAc1)19 mutation (C N ). Despite these differences, our results show that each reverse turn type is a suitable host for its corresponding enhanced aromatic sequon.
Adding N-glycans to naïve sites in proteins can be an attractive strategy for increasing their stability. This approach has been used in the development of protein drugs (45) (46) (47) (48) , where new N-glycans can extend serum half-life (49-51) and shelf-life, owing in part to increased protease resistance (52) , decreased aggregation propensity, and compensation for the destabilizing effect of methionine oxidation (53) . Historically, efforts to increase protein stability via N-glycosylation have depended on a trial-anderror approach (51, 54) , which often results in unpredictable energetic consequences (41, 55, 56) . By matching each enhanced aromatic sequon to an appropriate reverse turn conformation, we have provided engineering guidelines by which N-glycosylation can reliably stabilize proteins. These matches include PheAsn-Xxx-Thr for type I′ β-turns, Phe-Yyy-Asn-Xxx-Thr for type I β-bulge turns, and Phe-Yyy-Zzz-Asn-Xxx-Thr for type II β-turns within a six-residue loop. Each appears to facilitate native-state stabilizing interactions between Phe, Asn(GlcNAc) and Thr in glycosylation-naïve proteins that have not evolved to optimize protein-carbohydrate interactions (30) . The structurestability relationships unveiled by this work should also enable investigators to better predict which glycans can be removed from a glycoprotein to increase crystallization propensity, without yielding an unfolded or destabilized protein.
As noted earlier, the type I β-bulge turn and the type II β-turn in a six-residue loop (in which we previously applied the PheYyy-Asn-Xxx-Thr and Phe-Yyy-Zzz-Asn-Xxx-Thr sequons, respectively) comprise less than 9% of all reverse turns in the PDB (28, 33) . By successfully applying the Phe-Asn-Xxx-Thr enhanced aromatic sequon to the type I′ β-turn (which comprises nearly 11% of all reverse turns in the PDB), we have doubled the number of candidate proteins in which enhanced aromatic sequons can be employed without altering the conformation or the number of residues comprising the native reverse turn (57, 58) .
Materials and Methods
Protein Synthesis. WW domain variants were synthesized as C-terminal acids via solid-phase peptide synthesis, using the standard Fmoc protecting group strategy as described previously (41) , and in SI Text. Amino acids were activated by 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (Advanced ChemTech) and N-hydroxybenzotriazole hydrate (Advanced ChemTech). Fmoc-Gly-loaded Novasyn TGT resin and all Fmocprotected α-amino acids with acid-labile side-chain protecting groups were purchased from EMD Biosciences, including the glycosylated amino acid Fmoc-AsnðAc 3 GlcNAcÞ-OH (N-α-Fmoc-N-β-[3,4,6-tri-O-acetyl-2-(acetylamino)-deoxy-2-β-glucopyranosyl]-L-asparagine). Piperidine and N,N-diisopropylethylamine were procured from Aldrich, and N,N-dimethylformamide was obtained from Fisher.
Side-chain protecting groups were globally removed and proteins were cleaved from the resin by stirring the resin for approximately 4 h in a solution of phenol (0.5 g), water (500 μL), thioanisole (500 μL), ethanedithiol (250 μL), and triisopropylsilane (100 μL) in trifluoroacetic acid (TFA, 8 mL), and proteins were precipitated from the TFA solution by addition of diethyl ether (approximately 45 mL). Acetate protecting groups were subsequently removed from the 3-, 4-, and 6-hydroxyl groups of GlcNAc in Asn(GlcNAc)-containing proteins by hydrazinolysis, as described previously (41, 59) and in SI Text. The WW variants were purified by reverse-phase HPLC on a C18 column using a linear gradient of water in acetonitrile with 0.2% v∕v TFA. The identity of each WW variant was confirmed by matrix-assisted laser desorption/ionization time-of-flight spectrometry (MALDI-TOF; see Table S1 ), and purity was evaluated by analytical HPLC.
CD Measurements. CD measurements were made using an Aviv 62A DS spectropolarimeter, using quartz cuvettes with path lengths of 0.1 or 1 cm. WW domain solutions were prepared in 20 mM sodium phosphate buffer, pH 7; Fig. 3 . Origin of the increase in stability of 4-F,T, 5-F,T, and 6-F,T upon glycosylation. ΔΔG f;total (yellow bars) is the sum of the energetic effects of (1) the Asn19 to Asn(GlcNAc)19 mutation (C N , blue bars); (2) the two-way interaction between Phe16 and Asn(GlcNAc)19 (C F;N , red bars); (3) the two-way interaction between Asn(GlcNAc)19 and Thr21 (C N;T , green bars); and (4) the three-way interaction between Phe16, Asn(GlcNAc)19, and Thr21 (C F;N;T , purple bars). C N , C F;N , C N;T , and C F;N;T , are parameters obtained from leastsquares regression of Eq. 1; error bars represent the corresponding standard errors.
protein solution concentrations were determined spectroscopically from tyrosine and tryptophan absorbance at 280 nm in 6 M guanidine hydrochloride þ20 mM sodium phosphate (ϵ Trp ¼ 5690 M −1 cm −1 , ϵ Tyr ¼ 1280 M −1 cm −1 ) as described previously (41, 60) . CD spectra were obtained by monitoring molar ellipticity from 340 to 200 nm in 1 nm increments, with five-second averaging times. Variable temperature CD data were obtained by monitoring molar ellipticity at 227 nm from 0.2°C to 98.2°C or 108.2°C at 2°C intervals, with 90 s equilibration time between data points and 30 s averaging times. We fit the variable temperature CD data to obtain T m and ΔG f values for each protein, as described previously (41) , and in SI Text. The CD data for 4, 5, and 6, and their derivatives are shown in Figs. S1-S3.
